PALATIN TECHNOLOGIES, INC. Deferred Tax Assets, Operating Loss Carryforwards
PALATIN TECHNOLOGIES, INC. (PTN) had Deferred Tax Assets, Operating Loss Carryforwards of $46.05 million as of 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-09-23
- 2025-06-30: Deferred Tax Assets, Operating Loss Carryforwards $46.05M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards $40.05M.
- 2023-06-30: Deferred Tax Assets, Operating Loss Carryforwards $40.07M.
- 2022-06-30: Deferred Tax Assets, Operating Loss Carryforwards $35.33M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-06-30 | $46.05M 10-K · filed 2025-09-23 |
| 2024-06-30 | $40.05M 10-K · filed 2025-09-23 |
| 2023-06-30 | $40.07M 10-K · filed 2024-09-30 |
| 2022-06-30 | $35.33M 10-K · filed 2023-09-28 |
| 2021-06-30 | $32.17M 10-K · filed 2022-09-22 |
| 2020-06-30 | $24.32M 10-K · filed 2021-09-28 |
| 2019-06-30 | $18.72M 10-K · filed 2020-09-25 |
| 2018-06-30 | $29.50M 10-K · filed 2019-09-12 |
| 2017-06-30 | $103.84M 10-K · filed 2018-09-13 |
| 2016-06-30 | $114.08M 10-K · filed 2017-09-25 |
| 2015-06-30 | $94.33M 10-K · filed 2016-09-19 |
| 2014-06-30 | $87.80M 10-K · filed 2015-09-18 |
| 2013-06-30 | $83.47M 10-K · filed 2014-09-12 |
| 2012-06-30 | $81.46M 10-K · filed 2013-09-27 |
| 2011-06-30 | $76.81M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |